N-cyclopropyl-3-fluoro-5-(3-(2-hydroxypropan-2-yl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-4-methylbenzamide

ID: ALA2087526

PubChem CID: 25060876

Max Phase: Preclinical

Molecular Formula: C20H21FN4O2

Molecular Weight: 368.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccn2c(C(C)(C)O)nnc2c1

Standard InChI:  InChI=1S/C20H21FN4O2/c1-11-15(8-13(9-16(11)21)18(26)22-14-4-5-14)12-6-7-25-17(10-12)23-24-19(25)20(2,3)27/h6-10,14,27H,4-5H2,1-3H3,(H,22,26)

Standard InChI Key:  VASDBJLAJXMNPY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    2.7611   -7.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7599   -8.4773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4747   -8.8902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1912   -8.4769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1883   -7.6463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4729   -7.2372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9012   -7.2311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6172   -7.6409    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8981   -6.4061    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3302   -7.2258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1541   -7.2264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7389   -6.5135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0451   -8.8893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4745   -9.7152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7547  -10.1236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1815  -10.9504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1853  -10.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4651  -11.3615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7555  -10.9456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1406  -11.4919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4702  -12.2456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2883  -12.1651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7216  -12.8618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0465   -7.2376    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3327  -13.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5461  -12.8348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1292  -13.5708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2 13  1  0
  1  2  2  0
  3 14  1  0
 14 15  2  0
  5  7  1  0
  3  4  2  0
  7  8  1  0
 14 17  1  0
 15 19  1  0
 18 16  1  0
 16 17  2  0
 18 19  1  0
  7  9  2  0
  4  5  1  0
  8 10  1  0
 11 10  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 18  1  0
 12 11  1  0
 22 23  1  0
 10 12  1  0
  1 24  1  0
  2  3  1  0
 23 25  1  0
  5  6  2  0
 23 26  1  0
  6  1  1  0
 23 27  1  0
M  END

Associated Targets(Human)

MAPK13 Tchem MAP kinase p38 delta (2605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 368.41Molecular Weight (Monoisotopic): 368.1649AlogP: 2.96#Rotatable Bonds: 4
Polar Surface Area: 79.52Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.53CX Basic pKa: 1.24CX LogP: 1.95CX LogD: 1.95
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -1.18

References

1. Aiguadé J, Balagué C, Carranco I, Caturla F, Domínguez M, Eastwood P, Esteve C, González J, Lumeras W, Orellana A, Preciado S, Roca R, Vidal L, Vidal B..  (2012)  Novel triazolopyridylbenzamides as potent and selective p38α inhibitors.,  22  (10): [PMID:22521646] [10.1016/j.bmcl.2012.03.099]

Source